↓ Skip to main content

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer

Overview of attention for article published in Frontiers in oncology, July 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
twitter
11 X users

Citations

dimensions_citation
90 Dimensions

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
Published in
Frontiers in oncology, July 2021
DOI 10.3389/fonc.2021.693104
Pubmed ID
Authors

Mridula A. George, Sadaf Qureshi, Coral Omene, Deborah L. Toppmeyer, Shridar Ganesan

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 127 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 9%
Student > Bachelor 11 9%
Student > Master 9 7%
Student > Ph. D. Student 6 5%
Other 3 2%
Other 7 6%
Unknown 79 62%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 15 12%
Medicine and Dentistry 12 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Agricultural and Biological Sciences 3 2%
Nursing and Health Professions 2 2%
Other 9 7%
Unknown 80 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2024.
All research outputs
#2,404,594
of 26,493,631 outputs
Outputs from Frontiers in oncology
#557
of 23,231 outputs
Outputs of similar age
#55,569
of 452,689 outputs
Outputs of similar age from Frontiers in oncology
#25
of 1,370 outputs
Altmetric has tracked 26,493,631 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 23,231 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,689 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 1,370 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.